BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen HR, Lai YC, Yeh TM. Dengue virus non-structural protein 1: a pathogenic factor, therapeutic target, and vaccine candidate. J Biomed Sci 2018;25:58. [PMID: 30037331 DOI: 10.1186/s12929-018-0462-0] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 7.5] [Reference Citation Analysis]
Number Citing Articles
1 Ghosh N, Sharma N, Saha I, Saha S. Genome-wide analysis of Indian SARS-CoV-2 genomes to identify T-cell and B-cell epitopes from conserved regions based on immunogenicity and antigenicity. Int Immunopharmacol 2021;91:107276. [PMID: 33385714 DOI: 10.1016/j.intimp.2020.107276] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Zhou D, Li Q, Jia F, Zhang L, Wan S, Li Y, Song Y, Chen H, Cao S, Ye J. The Japanese Encephalitis Virus NS1' Protein Inhibits Type I IFN Production by Targeting MAVS. J Immunol 2020;204:1287-98. [PMID: 31996459 DOI: 10.4049/jimmunol.1900946] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
3 Reyes-Sandoval A, Ludert JE. The Dual Role of the Antibody Response Against the Flavivirus Non-structural Protein 1 (NS1) in Protection and Immuno-Pathogenesis. Front Immunol 2019;10:1651. [PMID: 31379848 DOI: 10.3389/fimmu.2019.01651] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 8.0] [Reference Citation Analysis]
4 Wellekens K, Betrains A, De Munter P, Peetermans W. Dengue: current state one year before WHO 2010-2020 goals. Acta Clin Belg 2022;77:436-44. [PMID: 33090941 DOI: 10.1080/17843286.2020.1837576] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 9.0] [Reference Citation Analysis]
5 Blahove MR, Carter JR. Flavivirus Persistence in Wildlife Populations. Viruses 2021;13:2099. [PMID: 34696529 DOI: 10.3390/v13102099] [Reference Citation Analysis]
6 Caraballo GI, Rosales R, Viettri M, Castillo JM, Cruz R, Ding S, Greenberg HB, Ludert JE. The Dengue Virus Nonstructural Protein 1 (NS1) Interacts with the Putative Epigenetic Regulator DIDO1 to Promote Flavivirus Replication in Mosquito Cells. J Virol 2022;:e0070422. [PMID: 35652656 DOI: 10.1128/jvi.00704-22] [Reference Citation Analysis]
7 Bachour Junior B, Batistuti MR, Pereira AS, de Sousa Russo EM, Mulato M. Electrochemical aptasensor for NS1 detection: Towards a fast dengue biosensor. Talanta 2021;233:122527. [PMID: 34215030 DOI: 10.1016/j.talanta.2021.122527] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
8 Seeherman S, Suzuki YJ. Viral Infection and Cardiovascular Disease: Implications for the Molecular Basis of COVID-19 Pathogenesis. Int J Mol Sci 2021;22:1659. [PMID: 33562193 DOI: 10.3390/ijms22041659] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Saravanan KS, Arjunan S, Kunjiappan S, Pavadai P, Sundar LM. Phytoconstituents as Lead Compounds for Anti-Dengue Drug Discovery. Adv Exp Med Biol 2021;1322:159-93. [PMID: 34258741 DOI: 10.1007/978-981-16-0267-2_7] [Reference Citation Analysis]
10 Martínez-Cuellar C, Lovera D, Galeano F, Gatti L, Arbo A. Non-structural protein 1 (NS1) of dengue virus detection correlates with severity in primary but not in secondary dengue infection. J Clin Virol 2020;124:104259. [PMID: 31968278 DOI: 10.1016/j.jcv.2020.104259] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
11 Zhu J, Kim J, Xiao X, Wang Y, Luo D, Jiang S, Chen R, Xu L, Zhang H, Moise L, Gutierrez AH, De Groot AS, Xiao G, Schoggins JW, Zhan X, Wang T, Xie Y. The immune vulnerability landscape of the 2019 Novel Coronavirus, SARS-CoV-2. bioRxiv 2020:2020. [PMID: 32908981 DOI: 10.1101/2020.02.08.939553] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
12 Sood A, Gautam I, Singh G, Joshi JC, Dahiya RS, Arora S. Blockade of protease-activated receptor 2 (PAR-2) attenuates vascular dyshomeostasis and liver dysfunction induced by dengue virus infection. Medical Hypotheses 2022;165:110898. [DOI: 10.1016/j.mehy.2022.110898] [Reference Citation Analysis]
13 Bhatnagar P, Sreekanth GP, Murali-Krishna K, Chandele A, Sitaraman R. Dengue Virus Non-Structural Protein 5 as a Versatile, Multi-Functional Effector in Host-Pathogen Interactions. Front Cell Infect Microbiol 2021;11:574067. [PMID: 33816326 DOI: 10.3389/fcimb.2021.574067] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Gore MM. Vaccines Against Dengue and West Nile Viruses in India: The Need of the Hour. Viral Immunol 2020;33:423-33. [PMID: 32320353 DOI: 10.1089/vim.2019.0122] [Reference Citation Analysis]
15 Rodriguez AK, Muñoz AL, Segura NA, Rangel HR, Bello F. Molecular characteristics and replication mechanism of dengue, zika and chikungunya arboviruses, and their treatments with natural extracts from plants: An updated review. EXCLI J 2019;18:988-1006. [PMID: 31762724 DOI: 10.17179/excli2019-1825] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
16 Awan M, Rauf S, Abbas A, Nawaz MH, Yang C, Shahid SA, Amin N, Hayat A. A sandwich electrochemical immunosensor based on antibody functionalized-silver nanoparticles (Ab-Ag NPs) for the detection of dengue biomarker protein NS1. Journal of Molecular Liquids 2020;317:114014. [DOI: 10.1016/j.molliq.2020.114014] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
17 Mishra R, Sood V, Banerjea AC. Dengue NS5 modulates expression of miR-590 to regulate ubiquitin-specific peptidase 42 in human microglia. FASEB Bioadv 2019;1:265-78. [PMID: 32123831 DOI: 10.1096/fba.2018-00047] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
18 Warner NL, Frietze KM. Development of Bacteriophage Virus-Like Particle Vaccines Displaying Conserved Epitopes of Dengue Virus Non-Structural Protein 1. Vaccines (Basel) 2021;9:726. [PMID: 34358143 DOI: 10.3390/vaccines9070726] [Reference Citation Analysis]
19 de Jong W, Asmarawati TP, Verbeek I, Rusli M, Hadi U, van Gorp E, Goeijenbier M. Point-of-care thrombocyte function testing using multiple-electrode aggregometry in dengue patients: an explorative study. BMC Infect Dis 2020;20:580. [PMID: 32762658 DOI: 10.1186/s12879-020-05248-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
20 Niranjan R, Sumitha M, Sankari T, Muthukumaravel S, Jambulingam P. Nonstructural protein-1 (NS1) of dengue virus type-2 differentially stimulate expressions of matrix metalloproteinases in monocytes: protective effect of paracetamol. International Immunopharmacology 2019;73:270-9. [DOI: 10.1016/j.intimp.2019.05.022] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
21 Kao YS, Yu CY, Huang HJ, Tien SM, Wang WY, Yang M, Anderson R, Yeh TM, Lin YS, Wan SW. Combination of Modified NS1 and NS3 as a Novel Vaccine Strategy against Dengue Virus Infection. J Immunol 2019;203:1909-17. [PMID: 31451673 DOI: 10.4049/jimmunol.1900136] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
22 Wang WH, Urbina AN, Lin CY, Yang ZS, Assavalapsakul W, Thitithanyanont A, Lu PL, Chen YH, Wang SF. Targets and strategies for vaccine development against dengue viruses. Biomed Pharmacother 2021;144:112304. [PMID: 34634560 DOI: 10.1016/j.biopha.2021.112304] [Reference Citation Analysis]
23 Huang H, Yang M, Chen H, Wang S, Chang C, Ho T, Kao Y, Tien S, Lin H, Chang P, Lai Y, Hsiao Y, Liu Y, Chao C, Anderson R, Yeh T, Lin Y, Wan S. A novel chimeric dengue vaccine candidate composed of consensus envelope protein domain III fused to C-terminal-modified NS1 protein. Vaccine 2022. [DOI: 10.1016/j.vaccine.2022.02.070] [Reference Citation Analysis]
24 Losada PX, DeLaura I, Narváez CF. Dengue Virus and Platelets: From the Biology to the Clinic. Viral Immunol 2022. [PMID: 35483090 DOI: 10.1089/vim.2021.0135] [Reference Citation Analysis]
25 Kaushik S, Dar L, Kaushik S, Yadav JP. Anti-dengue activity of super critical extract and isolated oleanolic acid of Leucas cephalotes using in vitro and in silico approach. BMC Complement Med Ther 2021;21:227. [PMID: 34496833 DOI: 10.1186/s12906-021-03402-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Alkaff AH, Saragih M, Fardiansyah MA, Tambunan USF. Role of Immunoinformatics in Accelerating Epitope-Based Vaccine Development against Dengue Virus. TOBIOCJ 2020;14:9-18. [DOI: 10.2174/1874091x02014010009] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
27 Lima D, Mendes Hacke AC, Ulmer B, Kuss S. Electrochemical sensing of trypanosome- and flavivirus-related neglected tropical diseases. Current Opinion in Electrochemistry 2021;30:100838. [DOI: 10.1016/j.coelec.2021.100838] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Lu ZY, Cheng MH, Yu CY, Lin YS, Yeh TM, Chen CL, Chen CC, Wan SW, Chang CP. Dengue Nonstructural Protein 1 Maintains Autophagy through Retarding Caspase-Mediated Cleavage of Beclin-1. Int J Mol Sci 2020;21:E9702. [PMID: 33352639 DOI: 10.3390/ijms21249702] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
29 Mishra R, Lahon A, Banerjea AC. Dengue Virus Degrades USP33-ATF3 Axis via Extracellular Vesicles to Activate Human Microglial Cells. J Immunol 2020;205:1787-98. [PMID: 32848034 DOI: 10.4049/jimmunol.2000411] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
30 Nath H, Mallick A, Roy S, Sukla S, Biswas S. Computational modelling supports that dengue virus envelope antibodies can bind to SARS-CoV-2 receptor binding sites: Is pre-exposure to dengue virus protective against COVID-19 severity? Comput Struct Biotechnol J 2021;19:459-66. [PMID: 33391633 DOI: 10.1016/j.csbj.2020.12.037] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
31 Chao CH, Wu WC, Lai YC, Tsai PJ, Perng GC, Lin YS, Yeh TM. Dengue virus nonstructural protein 1 activates platelets via Toll-like receptor 4, leading to thrombocytopenia and hemorrhage. PLoS Pathog 2019;15:e1007625. [PMID: 31009511 DOI: 10.1371/journal.ppat.1007625] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 13.0] [Reference Citation Analysis]
32 Abraham PR, R B, N PK, Kumar A. Dengue NS1 antigen kit shows high sensitivity for detection of recombinant dengue virus-2 NS1 antigen spiked with Aedes aegypti mosquitoes. Sci Rep 2021;11:23699. [PMID: 34880307 DOI: 10.1038/s41598-021-02965-x] [Reference Citation Analysis]
33 Li Q, Kang C. Structure and Dynamics of Zika Virus Protease and Its Insights into Inhibitor Design. Biomedicines 2021;9:1044. [PMID: 34440248 DOI: 10.3390/biomedicines9081044] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Ong E, Wong MU, Huffman A, He Y. COVID-19 Coronavirus Vaccine Design Using Reverse Vaccinology and Machine Learning. Front Immunol 2020;11:1581. [PMID: 32719684 DOI: 10.3389/fimmu.2020.01581] [Cited by in Crossref: 69] [Cited by in F6Publishing: 85] [Article Influence: 34.5] [Reference Citation Analysis]
35 Pan YH, Liao MY, Chien YW, Ho TS, Ko HY, Yang CR, Chang SF, Yu CY, Lin SY, Shih PW, Shu PY, Chao DY, Pan CY, Chen HM, Perng GC, Ku CC, King CC. Use of seroprevalence to guide dengue vaccination plans for older adults in a dengue non-endemic country. PLoS Negl Trop Dis 2021;15:e0009312. [PMID: 33793562 DOI: 10.1371/journal.pntd.0009312] [Reference Citation Analysis]